Register  |  Log In  |  Contact Us

Director of Authorisations - Veterinary Medicines Directorate - DEFRA

Reference
1549458
Contract Type
Permanent
Sector
Public Sector
Location
London
Salary
£80,000
Expiry Date
11/09/2017
The impact on veterinary medicines regulation of the UK exit from the EU remains unknown until the negotiations are completed. However, whatever the outcome, medicines will still need to be authorised and regulated.

Job Description

The impact on veterinary medicines regulation of the UK exit from the EU remains unknown until the negotiations are completed. However, whatever the outcome, medicines will still need to be authorised and regulated. Working relationships with other medicines agencies will need to be maintained, and the VMD partnership working with non-EU medicines agencies further strengthened. VMD preparations for a range of eventualities are well advanced. The new Director of Authorisations will play a full and leading part in the preparations, managing the transition and expanding our global influence.

The Authorisations function makes a vital contribution to the work of the VMD, and there is an essential contribution to be made by the Director of Authorisations in terms of corporate leadership and management. You will bring a proven record of managing high performing teams and working strategically, coupled with a focus on achievement and delivery. Your professional skills will include the ability to challenge constructively, and you will help to ensure that business decision-making is sound. Your communication skills will be excellent, as will your influencing and leadership skills. You will have a track record of effective people management, experience of developing highly performing teams, and the ability to deliver results through others, both in your own team and across the organisation. This is a busy post dealing with high volumes often with conflicting priorities.

Your representational and negotiation skills will be a key strength, enabling you to build strong relationships and develop effective strategies for both national and international issues. This work is vital, as it determines the guidelines and standards by which we increasingly operate within the widening network of organisations striving for convergence of veterinary medicines regulation. You will therefore have a strong external focus, undertaken alongside the oversight of ‘business as usual’ in UK licensing and surveillance which is a very significant part of the VMD role, and will require an ability to delegate effectively, empowering staff while retaining oversight of the quality of performance and service delivery.

 

Main responsibilities

 

  • Lead four teams of approximately 80 staff in total (currently 4 direct reports); £8m budget, to ensure the effective and timely authorisation of veterinary medicines in the UK by using good science to assess the quality, safety and efficacy data provided by applicants and sound administrative processes.
  • To ensure in all areas of responsibility adherence to the highest levels of probity in line with civil service values and standards of behaviour.  In particular this includes ensuring data protection and absence of conflicts of interest.
  • Agree clear operational standards and measures with staff and colleagues contributing to the effective performance of the VMD.
  • Operate sound business and financial practices to ensure delivery is achieved within the agreed parameters of value for money, putting the interests of customers and stakeholders at the forefront of outcomes.
  • Represent the VMD and Defra in the relevant National and International arenas for veterinary medicine regulation and act as an expert and ambassador for the UK in scientific working groups and policy debates.
  • As a member of the VMD, take an active part in strategic planning for the VMD and delivery of the business plan.
  • To identify and explore outreach opportunities to help develop medicines regulation capability in those countries where it is not well developed, and for the convergence of medicines regulations globally.
  • To help manage preparation for exit from the EU and the post-EU transition of VMD business